In vivo studies of DHTS, Wang et al. found that DHTS reversed metabolic reprogramming in colon cancer by regulating PTEN/Akt/HF1α mediated signaling pathways (Wang et al., 2018). The gene discussed is AKT1; the disease is malignant colon neoplasm.